Watson says court affirms ADHD drug patent ruling

Watson says court affirms ADHD drug patent ruling
Watson Pharmaceuticals Inc. said Monday that an appeals court affirmed that a disputed patent on Johnson & Johnson’s attention deficit drug Concerta is invalid.